The Killer 50
-
Bicycle Therapeutics firmly in the Nasdaq saddle after $60.6m IPO
Cambridge cancer drug innovator Bicycle Therapeutics, which raised $60.6 million on its Nasdaq IPO in the US, has settled nicely on the American... Read More
-
Featurespace digital onboarding solution tightens net on online fraudsters
Cambridge fraud-busting innovator Featurespace has launched Adaptive Behavioural Biometrics which uses in-session behavioural data collected from... Read More
-
Crescendo Biologics earns Takeda payout
Cambridge life science company Crescendo Biologics has achieved a fourth milestone in its collaboration with Takeda Pharmaceutical Company. The... Read More
-
Cambridge software proves arresting proposition for US police
Pioneering in-vehicle technology from Cambridge company VNC Automotive is being used in America to help first responders answer emergency callouts... Read More
-
Agile Analog
In May 2019, Agile Analog – spearheaded by senior ex-Arm innovators – secured $5 million funding to expand its engineering team to serve a growing... Read More
-
Sano Genetics
Cambridge startup Sano Genetics (formerly Heterogeneous) aims to enable large-scale genetic and medical research without sacrificing data privacy –... Read More
-
Cambridge Intelligence launches ReGraph for React developers
Cambridge Intelligence has launched an early access program for ReGraph, a new graph data visualisation toolkit. ReGraph is a React toolkit for... Read More
-
Summers a man with a Mission
Mission Therapeutics in Cambridge, whose technology promises cures for Alzheimer’s and Parkinson’s diseases, has added fresh muscle to its board with... Read More
-
Global double whammy for fast-growing Arecor
A global top 20 pharmaceutical giant is leveraging proprietary formulation technology from Arecor, the Chesterford Research Park-based company.... Read More
-
Closed Loop Medicine
Closed Loop Medicine (CLM) helps doctors and healthcare providers deliver personalised treatment regimens. CLM is a new breed of... Read More
-
Psyomics
A Cambridge University spin-out, Psyomics is combining digital approaches with developments in biomarker technology to benefit those facing mental... Read More
-
PolyProx Therapeutics
A spin-out from the Department of Pharmacology at the University of Cambridge, PolyProx is based on over a decade of research and intellectual... Read More
-
Morphogen-IX
Cambridge University spin-out, Morphogen-IX, is developing bone morphogenetic proteins (BMPs) to treat pulmonary arterial hypertension (PAH).... Read More
-
KisanHub
KisanHub, based at the Future Business Centre in Cambridge, is a software as a solutions service focused towards the AgriTech sector. CEO Dr... Read More
-
Isogenica
Isogenica – based at Chesterford Research Park – is a leader in the design and construction of highly diverse synthetic antibody libraries and the... Read More
-
NodThera advances lead candidate and adds two big hitters to board
NodThera, a Cambridge biotech company developing a new class of medicines that inhibit the NLRP3 inflammasome to treat chronic inflammation, has... Read More
-
Domainex helping to develop potential new heart drug
Domainex scientists in Cambridge, working with Professor Michael Schneider and his team at Imperial College, have found a potential new drug for... Read More
-
Mursla
Tokyo Institute of Technology spin-out, Mursla is developing a diagnostic device that leverages proprietary nanostructures to significantly... Read More
-
myrtle.ai
myrtle.ai has assembled a globally renowned team of experts with expertise in producing low power inference circuits and works with quoted businesses... Read More
-
Opus Materials Technologies
In December 2017, Cambridge-based Opus Materials Technologies secured close to £1million in funding from Innovate UK to validate and test the... Read More